These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24780574)

  • 1. [Diarrhoea and malabsorption due to olmesartan use].
    van Beurden YH; Nijeboer P; Janssen J; Verbeek WH; Mulder CJ
    Ned Tijdschr Geneeskd; 2014; 158():A7370. PubMed ID: 24780574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olmesartan enteropathy: an important cause of malabsorption and diarrhoea.
    Cook DR
    Intern Med J; 2020 Jan; 50(1):130-132. PubMed ID: 31943610
    [No Abstract]   [Full Text] [Related]  

  • 3. [Enteropathy by olmesartan].
    Téllez Villajos L; Crespo Pérez L; Cano Ruiz A; Moreira Vicente V
    Med Clin (Barc); 2015 Feb; 144(3):140-1. PubMed ID: 25194976
    [No Abstract]   [Full Text] [Related]  

  • 4. Olmesartan-Induced Enteropathy.
    Adike A; Corral J; Rybnicek D; Sussman D; Shah S; Quigley E
    Methodist Debakey Cardiovasc J; 2016; 12(4):230-232. PubMed ID: 28289500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enteropathy associated with chronic use of olmesartan].
    Téllez A; Pellicé M; Llobell A; Milisenda JC
    Med Clin (Barc); 2015 Feb; 144(3):139-40. PubMed ID: 24930862
    [No Abstract]   [Full Text] [Related]  

  • 6. Olmesartan-induced enteropathy.
    Onteddu NK; Pulivarthi VSKK; Ginnavaram M; Kedika R
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30279248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case of olmesartan-associated enteropathy and transient positive antitissue transglutaminase serology.
    Ghaith J; Raslan IA; Szilagyi A; Alameldin M
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute renal failure secondary to diarrhea due to sprue like-enteropathy associated with olmesartan].
    Ulla-Rocha JL; Lopez-Piñeiro S; Puga-Gimenez M
    Gastroenterol Hepatol; 2015 Oct; 38(8):514-5. PubMed ID: 25534549
    [No Abstract]   [Full Text] [Related]  

  • 9. [Enteropathy due to olmesartan].
    Ould Sidi Mohamed M; Colardelle P
    Ann Cardiol Angeiol (Paris); 2016 Apr; 65(2):95-8. PubMed ID: 26067144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In diarrhea of unknown origin also think of olmesartan!].
    Storr M
    MMW Fortschr Med; 2015 Mar; 157(4):34. PubMed ID: 25743974
    [No Abstract]   [Full Text] [Related]  

  • 11. [Olmesartan-associated enteropathy: attention to an emerging iatrogenic phenomenon].
    Modesto Dos Santos JL; González Recio P; Terry López OA; Leturia Frade I; Aguiar Losada B; Elejalde Guerra JI
    An Sist Sanit Navar; 2017 Aug; 40(2):291-294. PubMed ID: 28676728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An atypical case of chronic diarrhoea: olmesartan-induced sprue-like enteropathy.
    Naik DK; Martelli MG; Gonzalo DH; Sharma AK; Pannu D
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26370634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An emerging issue in differential diagnosis of diarrhea: sprue-like enteropathy associated with olmesartan.
    Imperatore N; Tortora R; Capone P; Caporaso N; Rispo A
    Scand J Gastroenterol; 2016 Mar; 51(3):378-80. PubMed ID: 26554620
    [No Abstract]   [Full Text] [Related]  

  • 14. [An unusual case of olmesartan induced enteropathy].
    Henry P; Dano H; Piessevaux H; Jouret-Mourin A
    Ann Pathol; 2019 Jun; 39(3):237-240. PubMed ID: 30712983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olmesartan-associated duodenal villous atrophy, an emerging clinical issue.
    Shukla N; Moore K; Gabb GM
    Intern Med J; 2020 May; 50(5):624-626. PubMed ID: 32431039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture.
    Abbruzzi F; Loconte I; Carparelli S; Ierardi E; Di Leo A; Principi M
    Curr Drug Saf; 2020; 15(1):65-68. PubMed ID: 31549594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olmesartan-associated enteropathy: new insights on the natural history? Report of two cases.
    Schiepatti A; Biagi F; Cumetti D; Luinetti O; Sonzogni A; Mugellini A; Corazza GR
    Scand J Gastroenterol; 2016; 51(2):152-6. PubMed ID: 26291698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature.
    Kulai T; Arnason T; MacIntosh D; Igoe J
    Can J Gastroenterol Hepatol; 2016; 2016():6091571. PubMed ID: 27446852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olmesartan-induced enteropathy treated with budesonide.
    Kempenaers S; Bogaert J; De Maeyer M; Van Hauthem P; Ramael M; Schoeters P
    Acta Gastroenterol Belg; 2019; 82(2):319-321. PubMed ID: 31314195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.
    Choi EY; McKenna BJ
    Arch Pathol Lab Med; 2015 Oct; 139(10):1242-7. PubMed ID: 26414468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.